CIPLA vs DRREDDY
Head-to-head DCF comparison · Cipla Limited vs Dr. Reddy's Laboratories Limited
It's a tie
CIPLA and DRREDDY are evenly matched on the 4 headline metrics.
CIPLA
Cipla Limited
Pharma
₹1,231
Data LimitedDRREDDY
Dr. Reddy's Laboratories Limited
Pharma
₹1,223
Undervalued| Metric | CIPLA | DRREDDY |
|---|---|---|
| Verdict | Data Limited | Undervalued |
| YieldIQ Score | 66/100 | 63/100 |
| Fair Value | ₹1,762 | ₹2,119 |
| Current Price | ₹1,231 | ₹1,223 |
| Margin of Safety | +43.1% | +73.3% |
| Moat | Narrow | Narrow |
| Piotroski F-Score | 7/9 | 6/9 |
| ROE | 16.9% | 16.8% |
| Debt / Equity | — | — |
| EV / EBITDA | 12.7× | 11.3× |
| Market Cap | ₹0.99 Lakh Cr | ₹1.02 Lakh Cr |
Run the full interactive analysis
DCF sliders, sensitivity tables, peer screens, watchlists — free to start.
Sign up free →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst.